BlackRock Investment Management’s Calithera Biosciences, Inc CALA Stock Holding History

BlackRock Investment Management’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8K	Hold	123	–	–	﹤0.01%	3678
2016 Q3	$8K	Hold	123	–	–	﹤0.01%	3681
2016 Q2	$9K	Sell	123 -2,035	-94%	-$204K	﹤0.01%	3682
2016 Q1	$245K	Buy	2,158 +31	+1%	+$3.51K	﹤0.01%	3122
2015 Q4	$326K	Buy	2,127 +7	+0.3%	+$1.05K	﹤0.01%	3147
2015 Q3	$230K	Hold	2,120	–	–	﹤0.01%	3228
2015 Q2	$303K	Buy	+2,120	New	+$491K	﹤0.01%	3227

Other funds holding CALA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Investment Management's CALA Position: Q4 2016 in Review

BlackRock Investment Management held its Calithera Biosciences, Inc (CALA) position steady in Q4 2016 at 123 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #3678.

BlackRock Investment Management first reported a position in CALA in Q2 2015 and has held it in 7 quarters since. The position peaked at $326K in Q4 2015. 33 funds tracked by Wall St. Rank hold CALA as of Q4 2016.

BlackRock Investment Management held 123 shares of Calithera Biosciences, Inc worth $8K as of Q4 2016.
BlackRock Investment Management left its Calithera Biosciences, Inc share count unchanged in Q4 2016.
Calithera Biosciences, Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3678 holding.
BlackRock Investment Management first reported a position in Calithera Biosciences, Inc in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's Calithera Biosciences, Inc position peaked at $326K in Q4 2015.
33 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.